moneycomecome wrote:可是生技的ETF(2915...(恕刪) ^NBI - NASDAQ BiotechnologyNasdaq GIDS - Nasdaq GIDS Delayed Price. Currency in USD3,286.11-5.12 (-0.16%)As of -. Market open.買進的時機點可能到了。
ambitiously wrote:中裕即時行情10/30...(恕刪) ^NBI - NASDAQ BiotechnologyNasdaq GIDS - Nasdaq GIDS Delayed Price. Currency in USD3,307.41+38.39 (+1.17%)As of -. Market open.
moneycomecome wrote:可是生技的ETF(2915...(恕刪) https://finance.yahoo.com/quote/%5ENBI^NBI - NASDAQ BiotechnologyNasdaq GIDS - Nasdaq GIDS Delayed Price. Currency in USD3,200.85-45.88 (-1.41%)As of -. Market open
生技新藥股的獲利模式不容易理解,臺灣第一家新藥股是中橡,研發孤兒藥「龐貝氏症」的生物制劑Myozyme,拿到藥證並有成功上市,權利金高達160億台幣,但是這麼多年以來,沒有看到中橡反映任何來自新藥的獲利,權利金完全不見了,如果你搞不清楚新藥真正的運作模式,就不要碰,別搞到血本無歸。